To establish a prospective registry for the active surveillance (AS) of prostate cancer (PC) using the Korean Urological Oncology Society (KUOS) database and to present interim analysis. The KUOS registry of AS for PC (KUOS-AS-PC) was organized in May 2019 and comprises multiple institutions nationwide.
The presence of lymph node metastasis is the most important prognostic indicator for patients with penile cancer. However, predicting which clinically node negative patients will harbor lymph node metastases remains unclear.
Therapies based on immune checkpoint inhibitors (ICIs) are transforming the treatment landscape of urologic oncology. Nevertheless, an exhaustive overview of the toxicity spectrum of these novel therapies has yet to be provided.
The aim of the study was to stratify high-grade T1 (HGT1) bladder urothelial carcinoma into risk categories based on the presence of variant histology when compared to conventional urothelial carcinoma.
The wide adoption of MRI and MRI-directed biopsies in the diagnostic workup of suspected prostate cancer (PCa) has ignited discussions about the appropriate balance between the benefits and harms of the biopsy decisions. The benefits arise from true MRI results and harms arise from false results. The very high sensitivity and negative predictive value of […]
The role of adjuvant therapy in muscle-invasive urothelial carcinoma is unclear, despite the high risk of metastatic recurrence. Adjuvant cisplatin-based chemotherapy is challenging to administer, and some patients are ineligible for or decline neoadjuvant cisplatin-based chemotherapy. Therefore, ongoing trials are designed to evaluate the efficacy of adjuvant immunotherapy.
Reno, Nevada (UroToday.com) — Photocure ASA, The Bladder Cancer Company, announces U.S. Food and Drug Administration (FDA) approval of a new and improved Blue Light system to be used with Photocure’s Cysview® product in Blue Light Cystoscopy (BLC®) procedures for the detection of non‐muscle invasive bladder cancer (NMIBC). Manufactured and soon to be commercialized by KARL STORZ […]
The Young Urologists Office is offering EAU members free participation in the online masterclass “The making of modern medicine: what they don’t tell you in med school”. Medical anthropologist and GP Dr. Sigrid Bregman (NL) will be challenging participants to take a different look at the medical profession in a fun and interactive way. Dr. […]
Background: Renal stones (nephrolithiasis and urolithiasis) and nephrocalcinosis are uncommon in children; however, their incidences in pediatric populations have been increasing. Patients and Methods: This multicenter retrospective study compared the clinical presentation, etiology, and outcomes of childhood nephrolithiasis or urolithiasis with those of nephrocalcinosis.
Holmium laser enucleation of the prostate (HoLEP) is currently the size-independent gold standard for surgical treatment of benign prostate enlargement (BPE). To systematically review the current literature and compare perioperative parameters, early outcomes, and complications after HoLEP with MOSES technology LEP (MoLEP) for BPE.
